Celgene Corporation to Announce Third Quarter 2012 Results on October 25, 2012

SUMMIT, N.J.--()--Celgene Corporation (NASDAQ: CELG) senior management will host a conference call and live audio webcast on Thursday, October 25, 2012 at 9 a.m. ET to discuss the company’s third quarter 2012 financial and operational results. The webcast will be available in the investor relations section of the Company’s Web site at www.celgene.com.

About Celgene

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the company’s Web site at www.celgene.com.

Contacts

Celgene Corporation
Jacqualyn A. Fouse, 908-673-9956
Executive Vice President and Chief Financial Officer
or
Patrick E. Flanigan III, 908-673-9969
Vice President, Investor Relations

Sharing

Contacts

Celgene Corporation
Jacqualyn A. Fouse, 908-673-9956
Executive Vice President and Chief Financial Officer
or
Patrick E. Flanigan III, 908-673-9969
Vice President, Investor Relations